Epidemiology Profile of Viral Meningitis Infections Among Patients in Qatar (2015–2018)

Autor: Shilu Mathew, Hebah A. Al Khatib, Khalid Al Ansari, Joanne Nader, Gheyath K. Nasrallah, Nadin N. Younes, Peter V. Coyle, Asmaa A. Al Thani, Muna A. Al Maslamani, Hadi M. Yassine

Publikováno v: Frontiers in Medicine, Vol 8 (2021)

Background: Little is known about the etiology of meningitis in the MENA region, including Qatar. Viral agents are considered the major cause for meningitis worldwide. Here, we present primary data about the etiology and clinical and demographic char

Externí odkaz: https://doaj.org/article/7b403569d1224f7b9b0ce7831c237d78

Plasmonic MXene-based nanocomposites exhibiting photothermal therapeutic effects with lower acute toxicity than pure MXene

Autor: Essraa A, Hussein, Moustafa M, Zagho, Balsam R, Rizeq, Nadin N, Younes, Gianfranco, Pintus, Khaled A, Mahmoud, Gheyath K, Nasrallah, Ahmed A, Elzatahry

Publikováno v: International Journal of Nanomedicine

Purpose: Here, we fabricated two plasmonic 2D Ti3C2Tx-based nanocomposites (Au/MXene and Au/Fe3O4/MXene) with similarly high anti-cancer photothermal therapy (PTT) capabilities, but with less in vivo toxicity than a pure MXene. Methods: Au/MXene was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::14433050b69d547565683682bbe17051
https://pubmed.ncbi.nlm.nih.gov/31417256

Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting.

Autor: Younes S; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar; Biomedical Sciences Department, College of Health Sciences, Qatar University, Doha, P.O. Box 2713, Qatar., Nicolai E; Department of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy., Younes N; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar; Biomedical Sciences Department, College of Health Sciences, Qatar University, Doha, P.O. Box 2713, Qatar., Pieri M; Department of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy; Clinical Biochemistry, Tor Vergata University Hospital, 00133 Rome, Italy., Bernardini S; Department of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy; Clinical Biochemistry, Tor Vergata University Hospital, 00133 Rome, Italy., Nizamuddin PB; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar; Biomedical Sciences Department, College of Health Sciences, Qatar University, Doha, P.O. Box 2713, Qatar., Al-Sadeq DW; Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, PO Box 2713, Doha, Qatar., Daas HI; College of Dental Medicine, QU Health, Qatar University, Doha, P.O. Box 2713, Qatar., Ismail A; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar., Yassine HM; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar; Biomedical Sciences Department, College of Health Sciences, Qatar University, Doha, P.O. Box 2713, Qatar., Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation, Education City, Doha, Qatar; Department of Healthcare Policy and Research, Weill Cornell Medicine, Cornell University, NY, USA., Nasrallah GK; Biomedical Research Center, Qatar University, Doha, P.O. Box 2713, Qatar; Biomedical Sciences Department, College of Health Sciences, Qatar University, Doha, P.O. Box 2713, Qatar. Electronic address: gheyath.nasrallah@qu.edu.qa.

Publikováno v: Vaccine [Vaccine] 2024 Oct 03; Vol. 42 (23), pp. 126042. Date of Electronic Publication: 2024 Jun 05.

Follow-Up and Comparative Assessment of SARS-CoV-2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA-1273 Heterologous Booster Vaccination.

Autor: Younes S; Biomedical Sciences Department, College of Health Sciences, Qatar University, Doha, Qatar.; Biomedical Research Center, Qatar University, Doha, Qatar., Nicolai E; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy., Pieri M; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.; Clinical Biochemistry, Tor Vergata University Hospital, Rome, Italy., Bernardini S; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.; Clinical Biochemistry, Tor Vergata University Hospital, Rome, Italy., Daas HI; College of Dental Medicine, QU Health, Qatar University, Doha, Qatar., Al-Sadeq DW; Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar., Younes N; Biomedical Sciences Department, College of Health Sciences, Qatar University, Doha, Qatar.; Biomedical Research Center, Qatar University, Doha, Qatar., Shurrab FM; Biomedical Research Center, Qatar University, Doha, Qatar., Nizamuddin PB; Biomedical Sciences Department, College of Health Sciences, Qatar University, Doha, Qatar., Humaira F; Biomedical Sciences Department, College of Health Sciences, Qatar University, Doha, Qatar., Al-Dewik N; Department of Research and Translational and Precision Medicine Research Lab, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.; Genomics and Precision Medicine (GPM), College of Health & Life Science (CHLS), Hamad Bin Khalifa University (HBKU), Doha, Qatar., Yassine HM; Biomedical Sciences Department, College of Health Sciences, Qatar University, Doha, Qatar.; Biomedical Research Center, Qatar University, Doha, Qatar., Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.; Department of Healthcare Policy and Research, Weill Cornell Medicine, Cornell University, New York, USA., Ismail A; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar., Nasrallah GK; Biomedical Sciences Department, College of Health Sciences, Qatar University, Doha, Qatar.; Biomedical Research Center, Qatar University, Doha, Qatar.

Publikováno v: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 May; Vol. 18 (5), pp. e13290.

Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months.

Autor: Younes S; Biomedical Research Center, Qatar University, P.O. Box, 2713, Doha, Qatar; Biomedical Sciences Department, College of Health Sciences, Qatar University, P.O. Box 2713, Doha, Qatar., Nicolai E; Department of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy., Al-Sadeq DW; Biomedical Research Center, Qatar University, P.O. Box, 2713, Doha, Qatar; College of Medicine, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar., Younes N; Biomedical Research Center, Qatar University, P.O. Box, 2713, Doha, Qatar; Biomedical Sciences Department, College of Health Sciences, Qatar University, P.O. Box 2713, Doha, Qatar., Al-Dewik N; Department of Pediatrics, Clinical and Metabolic Genetics, Hamad Medical Corporation, Doha, Qatar., Abou-Saleh H; Biomedical Research Center, Qatar University, P.O. Box, 2713, Doha, Qatar; Biological Science Program, Department of Biological and Environmental Sciences, College of Arts and Science, Qatar University, P.O. Box 2713, Doha, Qatar., Abo-Halawa BY; Biological Science Program, Department of Biological and Environmental Sciences, College of Arts and Science, Qatar University, P.O. Box 2713, Doha, Qatar., Eid AH; Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha P.O. Box, 2713, Qatar., Pieri M; Department of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy; Clinical Biochemistry, Tor Vergata University Hospital, 00133 Rome, Italy., Liu N; Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China., Daas HI; College of Dental Medicine, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar., Yassine HM; Biomedical Research Center, Qatar University, P.O. Box, 2713, Doha, Qatar; Biomedical Sciences Department, College of Health Sciences, Qatar University, P.O. Box 2713, Doha, Qatar., Nizamuddin PB; Biomedical Research Center, Qatar University, P.O. Box, 2713, Doha, Qatar., Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar; Department of Healthcare Policy and Research, Weill Cornell Medicine, Cornell University, New York, USA., Nasrallah GK; Biomedical Research Center, Qatar University, P.O. Box, 2713, Doha, Qatar; Biomedical Sciences Department, College of Health Sciences, Qatar University, P.O. Box 2713, Doha, Qatar. Electronic address: gheyath.nasrallah@qu.edu.qa.

Publikováno v: Journal of infection and public health [J Infect Public Health] 2023 Nov; Vol. 16 (11), pp. 1729-1735. Date of Electronic Publication: 2023 Aug 22.